Submissions for this category have closed.

TCT devotes committed blocks of time to exploring the newest developments in the field, known at the conference as Late-Breaking Clinical Trials. These are typically first-time presentations of first-in-man experiences with novel devices or drugs; the primary or important secondary endpoint results of prospective, randomized clinical trials; or large-scale, impactful single-/multicenter registries.

Accepted submissions will be presented in the Main Arena at TCT 2019 and during press conferences scheduled on the same days as Main Arena presentations.

If you have questions or need clarification, please e-mail .

A complete list of Late-Breaking Clinical Trials and Science is forthcoming.